Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 01 tags : Positive save search
Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 DISCREET Study In Moderate To Severe Genital Psoriasis
Published: 2021-12-01 (Crawled : 22:00) - biospace.com/
BGNE | $131.15 1.26% 1.24% 150K
|
Health Technology
|
| O: 3.7%
H: 3.74%
C: -0.91%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: 0.78%
H: 2.59%
C: 0.18%
psoriasis positive results phase 3 topline
U.S. Gold Corp. Announces Positive Prefeasibility Study Citing a Pre-Tax NPV of $323 Million and IRR of 39.4%
Published: 2021-12-01 (Crawled : 15:00) - prnewswire.com
USAU P | $4.11 -5.95% -6.33% 120K
|
Non-Energy Minerals
|
| O: 4.37%
H: 3.56%
C: -3.83%
positive
Astellas to Present Research on FLT3 Mutation-Positive Acute Myeloid Leukemia - from Diagnosis to Relapse - at 2021 American Society of Hematology Annual Meeting
Published: 2021-12-01 (Crawled : 14:30) - biospace.com/
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: 3.97%
H: 0.0%
C: -3.85%
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
|
| O: -2.8%
H: 3.17%
C: 1.06%
ema myeloid leukemia leukemia research positive diagnostic acute myeloid leukemia
Vertex Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal Segmental Glomerulosclerosis
Published: 2021-12-01 (Crawled : 13:30) - biospace.com/
VRTX | $400.07 1.47% 1.45% 1.3M
|
Health Technology
|
| O: 3.24%
H: 5.25%
C: 4.81%
phase 2 media positive results positive results sclerosis
Rallybio Reports Positive Data in Its Clinical Program for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Published: 2021-12-01 (Crawled : 13:00) - biospace.com/
RLYB | News | $1.79 1.7% 1.68% 270K
|
|
| O: -2.17%
H: 0.0%
C: -12.62%
positive
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
Published: 2021-12-01 (Crawled : 12:30) - globenewswire.com
CMPS | $8.33 -0.6% -0.6% 360K
|
Health Technology
|
| O: 6.29%
H: 0.0%
C: -8.02%
treatment comp360 trial positive results positive therapy results depression psilocybin
Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the Ongoing Open-Label SHORELINE Study in Patients with MDD
Published: 2021-12-01 (Crawled : 12:30) - biospace.com/
SAGE | $12.91 -3.15% -3.25% 800K
|
Health Technology
|
| O: 1.76%
H: 0.51%
C: -5.42%
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
|
| O: 0.21%
H: 1.1%
C: -3.16%
ongoing therapeutics positive
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.